157169-71-6

Usage

Uses

Used in Organic Synthesis:
2-[5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ETHANOL is used as an intermediate in organic synthesis for the development of various chemical compounds. Its unique structure allows for versatile reactions and the formation of diverse products.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-[5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ETHANOL is used as a building block for the design and synthesis of new pharmaceutical agents. Its potential pharmacological properties make it a promising candidate for the development of drugs targeting various diseases and conditions.
Used in Pharmaceutical Development:
2-[5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ETHANOL is used as a key component in the creation of novel pharmaceuticals. Its unique structure and potential bioactivity contribute to the development of innovative treatments for a range of medical needs.
Used in Chemical Research:
In the realm of chemical research, 2-[5-METHYL-2-(4-METHYLPHENYL)-1,3-OXAZOL-4-YL]ETHANOL is employed as a subject of study to explore its chemical properties, reactivity, and potential applications in various chemical processes.

Upstream product

• 157169-68-1 2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)acetic acid methyl ester 
• 1352085-98-3 3-bromo-4-carbonylpentyl benzoate 
• 31636-92-7 4-carbonylpentyl benzoate 
• 30414-53-0 methyl propanoyl acetate 
• 1071-73-4 5-Hydroxy-2-pentanone 
• 1383439-54-0 C₂₀H₁₉NO₃ 
• 1352086-01-1 3-amine-4-carbonylpentyl benzoate 
• 1352085-99-4 3-azido-4-carbonylpentyl benzoate 
• 619-55-6 para-methylbenzamide 
• 105983-77-5 methyl 4-bromo-3-oxopentanoate 
• 496060-65-2 3-acetyl-3-(4-methylbenzoylamino)propanoic acid methyl ester 
• 874-60-2 4-methyl-benzoyl chloride 

Downstream Products

• 868605-46-3 2-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]ethyl 4-methylbenzenesulfonate 
• 908373-17-1 C₂₄H₂₁NO₆ 
• 477541-32-5 methanesulfonic acid 2-(5-methyl-2-p-tolyloxazol-4-yl)ethyl ester 
• 1383439-81-3 C₂₅H₂₉NO₄ 
• 1352085-91-6 3-{2-ethyl-4-[2-(5-methyl-2-p-tolyloxazol-4-yl)ethoxy]phenyl}propanoic acid 
• 439803-80-2 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-3,4-dihydronaphthalen-1-yl)propanenitrile 
• 496060-66-3 methyl (2S)-2-((1S)-5-{2-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]ethoxy}-2,3-dihydro-1H-inden-1-yl)butanoate 
• 103788-12-1 5-{4-[2-(5-Methyl-2-m-tolyl-oxazol-4-yl)-ethoxy]-benzyl}-thiazolidine-2,4-dione 
• 103789-03-3 2-Imino-5-{4-[2-(5-methyl-2-m-tolyl-oxazol-4-yl)-ethoxy]-benzyl}-thiazolidin-4-one 
• 141399-49-7 4-[2-(5-Methyl-2-p-tolyl-oxazol-4-yl)-ethoxy]-phenylamine 

Relevant academic research and scientific papers

METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.

METHODS OF DOSE ADMINISTRATION FOR TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders.

Design and synthesis of 3-(2-ethyl-4-{2-[2-(4-fluorophenyl)- 5-methyloxazol-4-yl]ethoxy}phenyl)propanoic acid: A novel triple-acting PPARα, -γ, and -δ Agonist

The design and synthesis of triple-acting PPARα, -γ, and -δ agonist 3-(2-ethyl-4-{2-[2-(4-fluorophenyl)-5-methyloxazol-4-yl]- ethoxy}phenyl)propanoic acid (1a) is described. The compound possesses a potent triple-acting PPARα, -γ, and -δ agonist profile with an EC50 of 0.029, 0.013, and 0.029 μM, respectively. The synthetic route, involving the synthesis of oxazole rings as the key step, starts from commercially available 3-oxopentanoic acid methyl ester and 3- hydroxyacetophenone to afford the target compound 1 with an overall yield of 32%.

METHODS OF TREATING OR PREVENTING PSORIASIS, AND/OR ALZHEIMER'S DISEASE USING INDANE ACETIC ACID DERIVATIVES

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing psoriasis and/or Alzheimer's diseases.

METHOD FOR INCREASING SPECIFIC SURFACE AREA OF SLIGHTLY SOLUBLE DRUG

The preparation method of the powder of which dissolution rate improves is characterized by including of the process that slightly soluble drug having acidic group (e.g., 3-(5-{2-[5-methyl-2-(4-methylphenyl)-1,3-oxazol-4-yl]ethoxy}-3,4-dihydronaphthalen-1

TETRAHYDROQUINOLINE DERIVATIVE COMPOUND AND DRUG CONTAINING THE COMPOUND AS ACTIVE INGREDIENT

A compound of formula (I) (wherein all symbols are as defined in the specification) and salt thereof, and peroxisome proliferator activated receptor regulator comprising thereof as active ingredient. Because a compound of formula (I) have an activity of r

METHOD FOR PRODUCING ARYL OXAZOLYL ETHYL ALCOHOL

The invention relates to a method for producing an aryl oxazolyl ethyl alcohol of formula (I), which constitutes an intermediate stage in the production of medicaments. Said method comprises the reduction of a compound of formula (II) using an aqueous sol

DIHYDRONAPHTHALENE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THESE COMPOUNDS AS THE ACTIVE INGREDIENT

A compound of formula (I) (wherein all symbols are as defined in the specification) and salt thereof, and peroxisome proliferator activated receptor regulator comprising thereof as active ingredient. Because a compound of formula (I) have an activity of regulating peroxisome proliferator activated receptor regulator, the compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or treatment agent for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diabetes or syndrome X.

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.

Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5- lipoxygenase

Azole phenoxy hydroxyureas are a new class of 5-lipoxygenase (5-LO) inhibitors. Structure-activity relationship studies have demonstrated that electronegative substituents on the 2-phenyl portion of the oxazole tail increased the ex vivo potency of these